HDII — Hypertension Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.61m
- $3.79m
Annual cashflow statement for Hypertension Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2011 June 30th | 2012 June 30th | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-Q |
| Standards: | USG | USG | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.406 | -1.26 | -0.622 | -0.369 | -0.125 |
| Depreciation | |||||
| Non-Cash Items | -0.603 | -0.13 | 0.031 | 0.045 | 0.067 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.008 | 0.061 | 0.171 | 0.206 | -0.364 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.205 | -1.23 | -0.385 | -0.086 | -0.386 |
| Capital Expenditures | 0 | -0.631 | -0.002 | -0.002 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.125 | 0.25 | 0 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.125 | -0.381 | -0.002 | -0.002 | -0.002 |
| Financing Cash Flow Items | 0 | -0.008 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.03 | 0.927 | 0.264 | 0.183 | 0.189 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.3 | -0.679 | -0.123 | 0.095 | -0.199 |